Concourse Financial Group Securities, Inc. Dexcom Inc Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$59.83 - $87.57 $0 - $0	0 New	0 $0
Q1 2025 May 14, 2025	SELL	$67.74 - $90.75 $385,779 - $516,821	-5,695 Closed	0 $0
Q4 2024 Feb 13, 2025	BUY	$65.68 - $81.01 $7,618 - $9,397	116 Added 2.08%	5,695 $442,000
Q3 2024 Oct 10, 2024	SELL	$64.0 - $116.06 $137,472 - $249,296	-2,148 Reduced 27.8%	5,579 $373,000
Q2 2024 Jul 23, 2024	SELL	$110.31 - $140.45 $146,381 - $186,377	-1,327 Reduced 14.66%	7,727 $876,000
Q1 2024 Apr 30, 2024	SELL	$114.22 - $140.1 $67,960 - $83,359	-595 Reduced 6.17%	9,054 $1.26 Million
Q4 2023 Feb 07, 2024	BUY	$75.49 - $124.16 $37,443 - $61,583	496 Added 5.42%	9,649 $1.2 Million
Q3 2023 Oct 25, 2023	BUY	$86.06 - $137.93 $62,823 - $100,688	730 Added 8.67%	9,153 $853,000
Q2 2023 Aug 10, 2023	SELL	$112.47 - $130.98 $34,753 - $40,472	-309 Reduced 3.54%	8,423 $1.08 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $33,904 - $40,071	-326 Reduced 3.6%	8,732 $1.01 Million
Q4 2022 Jan 30, 2023	SELL	$84.98 - $122.67 $120,586 - $174,068	-1,419 Reduced 13.54%	9,058 $0
Q3 2022 Nov 15, 2022	SELL	$76.35 - $94.18 $53,521 - $66,020	-701 Reduced 6.27%	10,477 $844,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $567,512 - $1.11 Million	8,347 Added 294.84%	11,178 $833,000
Q1 2022 May 09, 2022	SELL	$94.08 - $130.2 $167,838 - $232,276	-1,784 Reduced 38.66%	2,831 $1.45 Million
Q4 2021 Feb 07, 2022	BUY	$129.87 - $162.82 $13,376 - $16,770	103 Added 2.28%	4,615 $2.48 Million
Q3 2021 Nov 09, 2021	BUY	$106.71 - $143.18 $12,591 - $16,895	118 Added 2.69%	4,512 $2.47 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $26,807 - $35,724	331 Added 8.15%	4,394 $469,000
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $111,244 - $137,418	1,312 Added 47.69%	4,063 $1.46 Million
Q4 2020 Feb 02, 2021	BUY	$78.0 - $104.5 $45,942 - $61,550	589 Added 27.24%	2,751 $1.02 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $48,710 - $57,604	510 Added 30.87%	2,162 $891,000
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $34,912 - $58,674	557 Added 50.87%	1,652 $670,000
Q1 2020 May 13, 2020	BUY	$47.79 - $75.63 $15,101 - $23,899	316 Added 40.56%	1,095 $295,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $12,340 - $19,306	337 Added 76.24%	779 $170,000
Q3 2019 Nov 13, 2019	BUY	$35.53 - $43.8 $14,460 - $17,826	407 Added 1162.86%	442 $66,000
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $982 - $1,336	35 New	35 $4,000
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $0 - $0	0 New	0 $0

Others Institutions Holding DXCM

# of Institutions

1,093

Shares Held

369M

Call Options Held

5.39M

Put Options Held

5.04M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account